Moneycontrol PRO

you are here: HomeNewsBusinessStocksAlkem Labs falls 7% as German regulator accuses of data fudge

SHOW NAMES

Trending Topics

Sensex Live Zydus Lifescience Shares Aurobindo Pharma Shares Gold Vs Stocks IPOs this Week

business

Alkem Labs falls 7% as German regulator accuses of data fudge

Alkem informed exchanges that the company will be submitting a suitable clarifications to the European Medicines Agency within the stipulated timelines to enable the Committee for Medicinal Products for Human Use (CHMP) take a balanced risk-benefit view with respect to these two products.

first published: Apr 18, 2016 10:54 am

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347